Evidence map›Paper›PMID 38811226›Full record

ArticleInternal medicine (Tokyo, Japan)2025

Repeated Ischemic Stroke due to in situ Thrombus at the Middle Cerebral Artery in a Patient with Essential Thrombocythemia.

Toru Nakagami, Yuji Kato, Kaito Watanabe, Ryutaro Kimura, Tsugumi Sato, Takeshi Hayashi, Satoshi Suda

Abstract readCase Reports
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Toru NakagamiDepartment of Neurology and Cerebrovascular Medicine, Saitama Medical University International Medical Center, Japan.
Yuji KatoDepartment of Neurology and Cerebrovascular Medicine, Saitama Medical University International Medical Center, Japan.
Kaito WatanabeDepartment of Neurology and Cerebrovascular Medicine, Saitama Medical University International Medical Center, Japan.
Ryutaro KimuraDepartment of Neurology and Cerebrovascular Medicine, Saitama Medical University International Medical Center, Japan.
Tsugumi SatoDepartment of Pathology, Saitama Medical University International Medical Center, Japan.
Takeshi HayashiDepartment of Neurology and Cerebrovascular Medicine, Saitama Medical University International Medical Center, Japan.
Satoshi SudaDepartment of Neurology and Cerebrovascular Medicine, Saitama Medical University International Medical Center, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Essential thrombocythemia (ET) is a myeloproliferative neoplasm that is a rare cause of ischemic stroke. We herein report a 70-year-old man with JAK2 V617F mutation-positive ET who experienced ischemic stroke twice in 1 month due to transient stenosis. In both events, transient stenosis formed at the same curvature of the right middle cerebral artery, and the thrombus disappeared with the initiation of antiplatelet agents. The formation of in situ thrombus at the curvature of the intracranial vessels may be a unique characteristic of JAK2 V617F mutation-positive ET patients.

Indexed as

Intracranial ThrombosisIschemic StrokeMiddle Cerebral ArteryThrombocythemia, EssentialThrombosisAgedHumansJanus Kinase 2MalePlatelet Aggregation InhibitorsRecurrenceJAK2 protein, humanJanus Kinase 2Platelet Aggregation Inhibitorsessential thrombocytosisin situ thrombusischemic strokeneoplasm

Identifiers

PMID38811226
PMCPMC11802207

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.